Search Results for: THERAPEUTIC FOCUS Targeted Payload Therapies


April 1, 2014

ANTIBODY DRUG CONJUGATES – ADC Development Using SMARTag(TM) Technology April 1, 2014

Robyn M. Barfield, PhD, and David Rabuka, PhD, say that despite challenges, there has been progress in advancing complex compounds through clinical trials and successfully treating patients, and these bioconjugate compounds include a subset of molecules known as ADCs.

November 29, 2012

12/5/2012 November 29, 2012

Curis Announces Several Major Announcements Curis, Inc. recently announced it has licensed from Genentech, a member of the Roche Group,...
August 26, 2012

8/29/2012 August 26, 2012

Synergy Pharmaceuticals Acquires BMS Drug Synergy Pharmaceuticals Inc. recently announced it has signed an Asset Purchase Agreement with Bristol-Myers Squibb...
May 20, 2012

5/23/2012 May 20, 2012

Agilent to Acquire Cancer Diagnostic Company for $2.2 Billion Agilent Technologies Inc. and EQT, the Sweden-based private equity group, recently...
March 7, 2012

3/13/2012 March 7, 2012

Aegerion Pharmaceuticals Submits US & EU Marketing Applications Aegerion Pharmaceuticals, Inc. recently announced it has submitted an NDA to the...